Recent Advances in Cancer Diagnosis and Therapy
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 30 July 2025 | Viewed by 207
Special Issue Editors
Interests: obesity-related pathology; tumor pathology; histology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
According to the World Health Organization report, cancer continues to be one of the leading causes of death worldwide. A cancer diagnosis is often made in advanced stages when it is associated with a high risk of recurrence and metastasis. Thus, the early diagnosis of cancer is one the most significant strategies to decrease the cancer mortality rate. Currently, the approach for cancer diagnosis includes non-invasive imaging exams combined with molecular biology techniques and the pathological examination of tissue samples to establish the type and stage of the cancer. In addition, another main cancer-related research priority is to develop new therapeutic tools with a high response rate and limited side-effects.
This Special Issue aims to provide a platform for gathering updated research in cancer-related diagnosis and treatment, which may improve the prognosis of the oncologic patient.
Dr. Adriana Grigoraș
Dr. Hsin-Sheng Yang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- early diagnosis
- advanced therapy
- biomarkers
- immunohistochemistry
- molecular diagnosis
- metastasis
- prognosis
- targeted therapies
- combination therapies
- cancer pharmacology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
